Gillette India Ltd. announced its results for the quarter ended December 2021 and amidst a challenging market environment, the company delivered strong growth in the quarter expanding its revenue.
It has reported revenue of Rs 563.44 crore for the quarter ended December 2021, as against Rs 520.42 crore for the previous corresponding quarter, reflecting a growth of 8% on-year. Its revenue for the 6M ended December 2021 stood at Rs 1136.75 crore against Rs 1036.82 crore for the corresponding 6M period, up by 9.64% YoY.
Its PAT for the Q2 FY’22 stood at Rs 70.50 crore against Rs 81.90 crore for Q2 FY’21, down by 14% YoY. While PAT for the 6M period was Rs 152.43 crore against Rs 177.19 crore for the corresponding 6M period, down by 14% YoY.
Company’s EPS narrowed from the existing Rs 25.13 in Q2 FY’21 to Rs 21.64 in Q2 FY’22.
Both Grooming and the Oral Care businesses recorded strong high single-digit growth ahead of their categories. Company stated that profit narrowed due to elevated commodity costs and the base effect of the lower advertising promotion investments in the previous corresponding quarter due to pandemic.
Gillette India has also commenced marketing and selling of Braun in India which is the world’s most trusted grooming brand, expecting to generate further revenues and strengthen the company’s overall financial performance.
Gillette India closed at Rs 5,142 against its previous closing of Rs 5,295.30, down by Rs 153.30 or 2.90%. It touched day’s high and low of Rs 5,280 and Rs 5,140.10 respectively.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.